Dirk Locascio
Analyst · Morgan Stanley. Your line is open
Thank you, Pietro and good morning. I'll give a brief recap on 2021 and then discuss our financial outlook for 2022 and 2024 and I'll start on Page 6. Fourth quarter financial results were in line with our expectations. Our Q4 and fiscal year 2021 results were significant improvement over prior year and we ended the year with a solid foundation for further growth. Q4 net sales were $7.6 billion, which was an increase of 32% over the prior year and you'll likely recall that Q4 2020 had an extra week, which increased that period sales approximately 700 basis points. The 32% growth excludes the extra week. Total case growth increased 13% and 21% for independent restaurants. We produced very strong gross profit dollar growth again this quarter, with our highest gross profit per case of the year as our team very effectively managed inflation and optimized pricing more broadly. This caps a strong year as fiscal 2021 GP per case was the highest we've had since becoming a public company. Supply chain challenges continue through Q4 similar to others in our industry. Despite these challenges, we remain fully staffed in almost all markets and are continuing to build staffing for expected volume growth acceleration this year. We remain focused on increasing productivity of those hired in recent months. As Bill noted, we've seen improvement in productivity during Q4 and expect further improvements in 2022, reaching 2019 productivity levels around midyear. Our supply chain cost was higher in Q4 than Q3, mainly due to more associates earning sign on a retention bonuses, inflation, hiring and preparation for continued volume increases and retaining additional staff as a bit of an insurance policy. We successfully refinanced $2.7 billion of debt in 2021, taking advantage of attractive market conditions to further strengthen our balance sheet by extending tenure and replacing more of our secured floating-rate debt with unsecured fixed rate debt. And finally, we significantly improved our debt leverage this year with a three turn reduction and leveraged to 4.6 times at year-end. On Slide 7, as I mentioned, Q4 net sales increased 32% over 2020, and within sales, volume grew 13% excluding the extra week in 2020; food inflation was 14.4% and the remainder was related to sales mix. Our independent restaurant volume increased 20% excluding the extra week and we saw acceleration earlier in the quarter before Omicron impacts which bodes well for 2022. Q4 ends a year of significant sales and volume improvement over 2020. Full year total volume was up 19% and independent volume of 30%, each excluding the extra week in 2020. Adjusted EBITDA was $262 million for the quarter, a 51% increase over the prior year, we estimate the extra week in Q4 of 2020 increased EBITDA by $8 million, so excluding the extra week, adjusted EBITDA for Q4 increased 58% over prior year. Q4 adjusted EBITDA as a percent of sales increased to 3.4%. For the full year, our adjusted EBITDA increased 65% and EBITDA margin increased 70 basis points compared to 2020. We did experienced limited impact from Omicron in December and the more significant impact is in Q1 2022 which we think will be temporary. The Q4 P&L outcome was largely in line with our expectations, no real surprises in the way the quarter played out. Adjusted diluted EPS for Q4 was $0.38 and full year $1.55 per share, each up significantly over the prior year. And lastly, specific to Food Group, most of the integration was completed by the end of 2021. We have the last system conversion plan for this coming weekend and we are on track and confident to achieve the $65 million in synergies. Future discussions of Food Group will be incorporated into our discussions of the overall business. Operating cash flow for the fiscal year was $419 million, similar to prior year. In 2021 working capital was $300 million plus use of cash, as a result of receivables growth due to the significant growth in sales. While 2020 had the benefit of approximately $200 million working capital reduction due to lower sales. Our business has historically generated a significant amount of operating cash flow and we expect to grow that cash flow with EBITDA over time. And as I've already highlighted, we further strengthened our balance sheet as we decreased our leverage in fiscal 2021 to 4.6 times and we are well on our way toward our target net leverage ratio of 2.5 to 3 times. Turning to 2022, we expect continued increases in volume and earnings through the execution of our strategic initiatives to grow market share, increased gross margins and improved operational efficiencies. One point to call out is you will hear me talk about a higher 2022 adjusted diluted EPS range than we initially included in our press release earlier this morning. The numbers I'm talking about are correct and the press release has been updated to reflect these numbers. We expect to grow volume at 1.5 times the market for restaurants and grow at market for the remaining customer types. We expect to deliver to $1.2 billion to $1.3 billion of adjusted EBITDA and $1.95 to $2.25 adjusted diluted earnings per share in fiscal 2022. Omicron appears to be largely in the rearview mirror, however, it has had a meaningful impact on volume and supply chain costs in Q1 and likely to a more limited extent in Q2. We also plan to continue to temporarily carry additional supply chain headcount to ensure adequate staffing and service levels in the event of another impact from COVID. Our outlook range reflects these Omicron related costs and impacts, which we estimate at $80 million to $90 million. Going forward, we are optimistic about the continued rapid recovery of our business post on Omicron. If the U.S. does not have another significant COVID wave, we expect to be at the higher end of the earnings range, the lower end of the range takes into account the possibility of another similar wave. Specific to Q1 2022 and the Omicron impact, we are experiencing reduced volume and incremental supply chain costs. We've seen volume improve the last couple of weeks and are very encouraged it will continue to improve through Q1. Client appears to mostly be driven by customer staffing challenges and believe that the end customer demand will be robust as Omicron subsides. Historically, our Q1 EBITDA is lower than other quarters of the year at approximately 20% of our annual EBITDA dollars. With most of the Omicron impact expected in Q1, we expect Q1 EBITDA to be a lower percent of our full year EBITDA than normal this year. Assuming there's not another significant wave and macro volume improvement occurs, especially in healthcare and hospitality, we expect volume to return to 2019 levels sometime in half two. In 2022, we expect adjusted EBITDA margins to improve over fiscal 2021, along with continued strong gross profit per case and increased operational efficiencies. We continue to expect supply chain productivity to return to 2019 levels midyear and surpass by year-end. We're focused on returning our adjusted EBITDA margin to pre-COVID levels and increasing it further in the coming years. Prior to the pandemic, we grew EBITDA margins 90 basis points or 25% improvement from 2015 to 2019 and expect to build upon that track record. We're also providing additional guidance on interest expense and CapEx, cash CapEx. As we significantly increased earnings in 2022, we expect to further reduce debt and as a result, be near 3.5 times leverage by year-end. As Pietro said, we're executing a multiyear plan to deliver significant earnings growth from the combination of profitable volume growth and margin expansion. As we look further ahead to 2024, we expect to continue growing at 1.5 times the market for restaurants and at market for other customer types. We expect adjusted EBITDA to grow at roughly - grow to roughly $1.5 billion in 2023 and then reach approximately $1.7 billion in 2024 as a result of executing our balanced plan. We will likely be near or at 2019 EBITDA margins in 2023 and then exceed in 2024 as we return to an expectation of EBITDA margin improvement each year. Adjusted diluted EPS is estimated to be approximately $3.40 in 2024. CapEx is estimated at 1.3% to 1.4% of sales. With respect to leverage, we plan to reach our target leverage range of 2.5 times to 3 times in 2023 and remain in that range. As we approach the range, we will further evaluate return of capital options, such as share repurchases. Our focus is on executing the plan to achieve these 2024 targets. However, beyond 2024, we would likely expect a 6% to 7% adjusted EBITDA growth algorithm. I like to reiterate the relative contributions of the various pillars of our strategy as they contribute to our expected EBITDA growth. While we won't be breaking down the quantified impact of each initiative, we have provided impacts for each bucket of the plan which reflect the combined contribution of initiatives that Pietro, Andrew and Bill discussed. We expect to generate nearly $650 million of adjusted EBITDA in fiscal 2024 compared to 2021. We expect the contributions of our increased earnings to be significant, for each of these pillars. Volume is expected to contribute an estimated $290 million, gross margin expansion approximately $325 million and OpEx efficiency approximately $235 million, which is incremental to the $130 million of fixed cost reductions completed in 2020. Then we have annual OpEx cost inflation that we must mitigate through productivity and gross margin increases. OpEx inflation is estimated to total about $210 million over the three years. Pietro, Andrew and Bill covered the key drivers in each pillar, so I won't repeat them. We successfully grew independent restaurants at approximately 2x the market rate and increased gross margin per case more than OpEx per case driving operating leverage gains over multiple years pre-pandemic, so we know how to do this well. Our new operating model gives us line of sight through initiatives already underway to improve execution on cost reduction. And as you've heard, we are especially focused on supply chain where we have new leadership with strong capabilities. We are confident in our ability to deliver strong adjusted EBITDA growth via continued share gains, further gross margin improvement and a more intense focus on operational efficiency. These increased earnings will produce strong and growing cash flows, which we can then prudently allocate to reinvest in the business, reduce leverage, return capital to shareholders and opportunistically pursue tuck-in M&A. We estimate this will lead to adjusted diluted EPS of approximately $3.40 per share, which is more than a 40% increase over FY 2019. Pietro back to you.